Advertisement
Research Article| Volume 33, ISSUE 5, P737-744, May 1992

Download started.

Ok

Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.

Open AccessPublished:May 01, 1992DOI:https://doi.org/10.1016/S0022-2275(20)41437-3
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.
Previous ArticleLecithin:cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates.
Next ArticleA missense (Asp250—-Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
      This paper is only available as a PDF. To read, Please Download here.
      Plasma cholesteryl esters, synthesized within high density lipoproteins (HDL), may be transferred from HDL particles to other lipoproteins by plasma cholesteryl ester transfer protein (CETP). Alcohol consumption is associated with increased HDL cholesterol concentration and reduced plasma CETP activity. The alcohol-induced decrease in CETP activity may be due to a low concentration of CETP in plasma or the inhibition of CETP by specific inhibitor proteins or alterations in the composition of plasma lipoproteins. The first two possibilities are studied further in this paper using data on 47 alcohol abusers and 31 control subjects. The activity of CETP was measured as the rate of cholesteryl ester transfer between radio-labeled low density lipoproteins and unlabeled HDL using an in vitro method independent of endogenous plasma lipoproteins. Plasma CETP concentration was determined by a Triton-based radioimmunoassay. The alcohol abusers consuming alcohol (on average 154 g/day) had 28% higher HDL cholesterol (P less than 0.01), 27% lower plasma CETP concentration (P less than 0.001), and 22% lower plasma CETP activity (P less than 0.001) than the controls. Plasma CETP concentration showed a negative correlation with HDL cholesterol among all the subjects (r = -0.317, P less than 0.01) but not among the alcohol abusers alone (r = -0.102, N. S.). During 2 weeks of alcohol withdrawal, plasma CETP concentration and activity of 8 subjects increased, whereas HDL cholesterol decreased by 42% (P less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

      REFERENCES

        • Tall A.R.
        Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
        J. Clin. Invest. 1990; 86: 379-384
        • Fielding P.E.
        • Fielding C.J.
        • Havel R.J.
        Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma.
        J. Clin. Invest. 1983; 71: 449-460
        • Savolainen M.J.
        • Hannuksela M.
        • Seppanen S.
        • Kervinen K.
        • Kesaniemi Y.A.
        Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity.
        Eur. J. Clin. Invest. 1990; 20: 593-599
        • Khavari K.A.
        • Farber P.D.
        A profile instrument for the quantification and assessment of alcohol consumption. The Khavari alcohol test.
        J. Stud. Alcohol. 1978; 39: 1525-1539
        • Havel R.J.
        • Eder H.A.
        • Bradgon J.H.
        The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
        J. Clin. Invest. 1955; 34: 1345-1353
        • Groener J.E.M.
        • Pelton R.W.
        • Kostner G.M.
        Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma.
        Clin. Chem. 1986; 32: 283-286
        • Marcel Y.L.
        • McPherson R.
        • Hogue M.
        • Czarnecka H.
        • Zawadzki Z.
        • Weech P.K.
        • Whidock M.E.
        • Tall A.R.
        • Milne R.W.
        Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.
        J. Clin. Invest. 1990; 85: 10-17
        • Hesler C.B.
        • Swenson T.L.
        • Tall A.R.
        Purification and characterization of a human plasma cholesteryl ester transfer protein.
        J. Biol. Chem. 1987; 262: 2275-2282
        • Mann C.J.
        • Yen F.T.
        • Grant A.M.
        • Bihain B.E.
        Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
        J. Clin. Invest. 1991; 88: 2059-2066
        • Sparks D.L.
        • Frohlich J.
        • Lacko A.G.
        • Pritch-ard P.H.
        Relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients.
        Atherosclerosis. 1989; 77: 183-191
        • Groener J.E.M.
        • Van Rozen A.J.
        • Erkelens D.W.
        Cholesteryl ester transfer activity: localization and role in distribution of cholesteryl ester among lipoproteins in man.
        Atherosclerosis. 1984; 50: 261-271
        • Karsenty C
        • Baraona E.
        • Savolainen M.J.
        • Lieber C.S.
        Effects of chronic ethanol intake on mobilization and excretion of cholesterol in baboons.
        J. Clin. Invest. 1985; 75: 976-986
        • Franceschini G.
        • Chiesa G.
        • Sirtori C.R.
        Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients.
        Eur. J. Clin. Invest. 1991; 21: 384-388
        • Hayek T
        • Chajek-Shaul T.
        • Walsh A.
        • Azrolan N.
        • Breslow J.L.
        Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice.
        Arteriosclerosis. 1991; 11: 1295-1302
        • Tollefson J.H.
        • Liu A.
        • Albers J.J.
        Regulation of plasma lipid transfer by the high-density lipoproteins.
        Am. J. Physiol. 1988; 255: E894-E902
        • Morton R.E.
        • Zilversmit D.B.
        A plasma inhibitor of triglyceride and cholesteryl ester transfer activities.
        J. Biol. Chem. 1981; 256: 11992-11995
        • Son Y-S.C.
        • Zilversmit D.B.
        Purification and characterization of human plasma proteins that inhibit lipid transfer activities.
        Biochim. Biophys. Acta. 1984; 795: 473-480
        • Nishide T.
        • Tollefson J.H.
        • Albers J.J.
        Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein.
        J. Lipid Res. 1989; 30: 149-158
        • Faust R.A.
        • Albers J.J.
        Synthesis and secretion of plasma cholesteryl ester transfer protein by human hepatocarcinoma cell line, HepG2.
        Arteriosclerosis. 1987; 7: 267-275
        • Tollefson J.H.
        • Faust R.
        • Albers J.J.
        • Chait A.
        Secretion of a lipid transfer protein by human monocyte-derived macrophages.
        J. Biol. Chem. 1985; 260: 5887-5890
        • Swenson T.L.
        • Simmons J.S.
        • Hesler C.B.
        • Bisgaier C.
        • Tall A.R.
        Cholesteryl ester transfer protein is secreted by HepG2 cells and contains asparagine-linked carbohydrate and sialic acid.
        J. Biol. Chem. 1987; 262: 16271-16274
        • Jiang X.C
        • Moulin P.
        • Quinet E.
        • Goldberg I.J.
        • Yacoub L.K.
        • Agellon L.B.
        • Compton D.
        • Schnitzer-Polokoff R.
        • Tall A.R.
        Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA.
        J. Biol. Chem. 1991; 266: 4631-4639
        • Quinet E.
        • Tall A.
        • Ramakrishnan R.
        • Rudel L.
        Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins.
        J. Clin. Invest. 1991; 87: 1559-1566
        • Drayna D.
        • Jarnagin A.S.
        • McLean J.
        • Henzel W.
        • Kohr W.
        • Fielding C.
        • Lawn R.
        Cloning and sequencing of human cholesteryl ester transfer protein cDNA.
        Nature. 1987; 327: 632-634
        • Pape M.E.
        • Ulrich R.G.
        • Rea T.J.
        • Marotti K.R.
        • Melchior G.W.
        Evidence that the nonparenchymal cells of the liver are the principal source of cholesteryl ester transfer protein in primates.
        J. Biol. Chem. 1991; 266: 12829-12831
        • Stibler H.
        • Borg S.
        • Joustra M.
        Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish patent 8400587 - 5 ).
        Alcoholism. 1986; 10: 535-544
        • Nikkila E.A.
        • Kuusi T.
        • Taskinen M-R.
        Role of lipoprotein lipase and hepatic endothelial lipase in the metabolism of high density lipoproteins: a novel concept on cholesterol transport in HDL cycle.
        in: Carlson L.A. Pernow B. Metabolic Risk Factors in Ischemic Cardiovascular Disease. Raven Press, New York1982: 205-215
        • Luoma P.V.
        • Sotaniemi E.A.
        • Pelkonen R.O.
        • Ehnholm C.
        High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers.
        Res. Commun. Chem. Pathol. Pharmacol. 1982; 37: 91-96
        • Malmendier C.L.
        • Delcroix C.
        Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers.
        Clin. Chim. Acta. 1985; 152: 281-288
        • Ekman R.
        • Fex G.
        • Johansson B.G.
        • Nilsson-Ehle P.
        • Wadstein J.
        Changes in plasma high density lipoproteins and lipolytic enzymes after long-term, heavy ethanol consumption.
        Scand. J. Clin. Lab. Invest. 1981; 41: 709-715
        • Taskinen M-R.
        • Valimaki M.
        • Nikkila E.A.
        • Kuusi T.
        • Ehnholm C.
        • Ylikahri R.
        High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal.
        Metabolism. 1982; 31: 1168-1174

      Article info

      Publication history

      Published online: May 01, 1992

      Identification

      DOI: https://doi.org/10.1016/S0022-2275(20)41437-3

      Copyright

      © 1992 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.

      User license

      Creative Commons Attribution (CC BY 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution (CC BY 4.0)

      Permitted

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article
      • Reuse portions or extracts from the article in other works
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      ASBMB  ASBMB  ASBMB  ASBMB

      ISSN 0022-2275
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX